Overview
Pseudoviruses are laboratory-engineered viral particles that mimic the structural and functional characteristics of pathogenic viruses while being incapable of replication. They are created by packaging a reporter gene-containing core with the envelope proteins of target viruses, typically using systems like VSV-G or lentiviral backbones. These tools are indispensable in virology research, allowing scientists to study viral entry mechanisms, test neutralizing antibodies, and evaluate vaccine candidates under safe conditions. Their non-replicative nature permits use in BSL-2 labs for pathogens that would normally require higher containment levels.
Physical and Chemical Properties
Pseudoviruses exhibit physical properties similar to their parental viruses, with diameters typically ranging from 80-120 nm. Their buoyant density in sucrose gradients (1.1-1.2 g/cm³) helps in purification. The particles maintain the receptor-binding domains of wild-type viruses but lack functional genomic material. Stability varies by construct, with most remaining viable for 6-12 months at -80°C when properly aliquoted. Cryoprotectants like glycerol or DMSO may be added for freeze-thaw resilience. The particles are sensitive to detergents, extreme pH (<6 or >9), and temperatures above 37°C for extended periods.
Main Applications
In vaccine development, pseudoviruses serve as safe surrogates for neutralization assays, critical for COVID-19 and HIV vaccine research. They enable high-throughput screening of antibodies without handling live viruses. Pharmaceutical companies use them to evaluate entry inhibitors and antiviral compounds. Research applications include studying viral tropism through envelope protein swapping and investigating host cell receptor interactions. Some gene therapy vectors also utilize pseudotyping to target specific cell types while avoiding immune responses against common viral vectors.
Safety and Storage
While non-replicative, pseudoviruses require handling per the biosafety level of their parental virus's envelope proteins. For example, SARS-CoV-2 spike-bearing constructs warrant BSL-2 precautions. All waste should be inactivated with 10% bleach or autoclaving. Optimal storage involves single-use aliquots at -80°C in stabilizing buffers (often containing 10-20% glycerol). Avoid repeated freeze-thaw cycles, which reduce infectivity by 30-50% per cycle. Shipping typically requires dry ice with temperature monitoring to maintain stability during transit.
B2B Procurement Guide
When sourcing pseudoviruses, specify: 1) Envelope protein (e.g., SARS-CoV-2 Delta variant spike), 2) Reporter system (luciferase, GFP, or β-galactosidase), 3) Titer (commonly 1×10^8-10^9 IU/mL), and 4) Packaging system (lentiviral, VSV, etc.). Reputable suppliers provide certificates of analysis including titer verification, sterility testing, and endotoxin levels. For custom constructs, lead times average 4-8 weeks. Bulk orders (10+ aliquots) may reduce per-unit costs by 15-30%. Consider requesting matched controls (e.g., empty vector particles) for assay validation.
Related Manufacturers
- 主营：实验细胞、微生物菌种、微生物质控品、标准物质
- 主营：加帽酶、激活剂、甘氨酸、SARS假病毒、igg抗体、稳定液、玻璃板、试剂盒、脂蛋白、超纯水、激动剂、胆固醇、盐酸盐、因质粒、扩容剂、组化笔、驴抗人、预制胶、驴抗兔、生物驴、草甘膦、重组酶、生物素、曲拉通、去除剂、封闭液
- 主营：动物疫病诊断试剂盒
- 主营：假阳性、医用冷藏箱